De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
MGI Tech Inkomsten in het verleden
Verleden criteriumcontroles 0/6
MGI Tech's earnings have been declining at an average annual rate of -11%, while the Life Sciences industry saw earnings growing at 19.5% annually. Revenues have been declining at an average rate of 16.2% per year.
Belangrijke informatie
-11.0%
Groei van de winst
6.2%
Groei van de winst per aandeel
| Life Sciences Groei van de industrie | 26.8% |
| Inkomstengroei | -16.2% |
| Rendement op eigen vermogen | -9.9% |
| Nettomarge | -30.2% |
| Volgende winstupdate | 31 Oct 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe MGI Tech geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 2,677 | -808 | 1,477 | 869 |
| 31 Mar 24 | 2,823 | -659 | 1,475 | 894 |
| 31 Dec 23 | 2,911 | -607 | 1,414 | 910 |
| 30 Sep 23 | 3,145 | -193 | 1,257 | 931 |
| 30 Jun 23 | 3,313 | 1,585 | 1,247 | 897 |
| 31 Mar 23 | 3,630 | 1,534 | 1,279 | 877 |
| 31 Dec 22 | 4,231 | 2,026 | 1,246 | 814 |
| 30 Sep 22 | 4,372 | 2,046 | 1,349 | 677 |
| 30 Jun 22 | 4,331 | 402 | 1,281 | 550 |
| 31 Mar 22 | 4,169 | 613 | 1,193 | 623 |
| 31 Dec 21 | 3,929 | 484 | 1,222 | 608 |
| 30 Sep 21 | 3,887 | 555 | 1,232 | 670 |
| 31 Dec 20 | 2,780 | 261 | 1,063 | 700 |
| 31 Dec 19 | 1,091 | -244 | 304 | 343 |
| 31 Dec 18 | 1,097 | 125 | 225 | 254 |
| 31 Dec 17 | 802 | -42 | 196 | 245 |
Kwaliteitswinsten: 688114 is currently unprofitable.
Groeiende winstmarge: 688114 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 688114 is unprofitable, and losses have increased over the past 5 years at a rate of 11% per year.
Versnelling van de groei: Unable to compare 688114's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: 688114 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-7.5%).
Rendement op eigen vermogen
Hoge ROE: 688114 has a negative Return on Equity (-9.9%), as it is currently unprofitable.